These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26176026)

  • 61. One-pot synthesis of redox-responsive polymers-coated mesoporous silica nanoparticles and their controlled drug release.
    Sun JT; Piao JG; Wang LH; Javed M; Hong CY; Pan CY
    Macromol Rapid Commun; 2013 Sep; 34(17):1387-94. PubMed ID: 23881541
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Functionalized mesoporous silica nanoparticle-based visible light responsive controlled release delivery system.
    Knežević NŽ; Trewyn BG; Lin VS
    Chem Commun (Camb); 2011 Mar; 47(10):2817-9. PubMed ID: 21240408
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Two-dimensional magnetic WS2@Fe3O4 nanocomposite with mesoporous silica coating for drug delivery and imaging-guided therapy of cancer.
    Yang G; Gong H; Liu T; Sun X; Cheng L; Liu Z
    Biomaterials; 2015 Aug; 60():62-71. PubMed ID: 25985153
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
    Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
    Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A dual-responsive mesoporous silica nanoparticle for tumor-triggered targeting drug delivery.
    Xiao D; Jia HZ; Zhang J; Liu CW; Zhuo RX; Zhang XZ
    Small; 2014 Feb; 10(3):591-8. PubMed ID: 24106109
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mesoporous silica nanoparticles loading doxorubicin reverse multidrug resistance: performance and mechanism.
    Shen J; He Q; Gao Y; Shi J; Li Y
    Nanoscale; 2011 Oct; 3(10):4314-22. PubMed ID: 21892492
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Orthogonal self-assembly of an organoplatinum(II) metallacycle and cucurbit[8]uril that delivers curcumin to cancer cells.
    Datta S; Misra SK; Saha ML; Lahiri N; Louie J; Pan D; Stang PJ
    Proc Natl Acad Sci U S A; 2018 Aug; 115(32):8087-8092. PubMed ID: 30038010
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Polymer-Coated Hollow Mesoporous Silica Nanoparticles for Triple-Responsive Drug Delivery.
    Zhang Y; Ang CY; Li M; Tan SY; Qu Q; Luo Z; Zhao Y
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):18179-87. PubMed ID: 26221866
    [TBL] [Abstract][Full Text] [Related]  

  • 69. pH-sensitive poly(glutamic acid) grafted mesoporous silica nanoparticles for drug delivery.
    Zheng J; Tian X; Sun Y; Lu D; Yang W
    Int J Pharm; 2013 Jun; 450(1-2):296-303. PubMed ID: 23598077
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A photoinduced pH jump applied to drug release from cucurbit[7]uril.
    Carvalho CP; Uzunova VD; Da Silva JP; Nau WM; Pischel U
    Chem Commun (Camb); 2011 Aug; 47(31):8793-5. PubMed ID: 21735013
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Synthesis of sol-gel mesoporous silica materials providing a slow release of doxorubicin.
    Prokopowicz M; Przyjazny A
    J Microencapsul; 2007 Nov; 24(7):682-701. PubMed ID: 17763062
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Enzyme-responsive cell-penetrating peptide conjugated mesoporous silica quantum dot nanocarriers for controlled release of nucleus-targeted drug molecules and real-time intracellular fluorescence imaging of tumor cells.
    Li J; Liu F; Shao Q; Min Y; Costa M; Yeow EK; Xing B
    Adv Healthc Mater; 2014 Aug; 3(8):1230-9. PubMed ID: 24550203
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Defect-related luminescent mesoporous silica nanoparticles employed for novel detectable nanocarrier.
    Ge K; Zhang C; Jia G; Ren H; Wang J; Tan A; Liang XJ; Zang A; Zhang J
    ACS Appl Mater Interfaces; 2015 May; 7(20):10905-14. PubMed ID: 25943277
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Time-resolved fluorescence anisotropy as a tool to study guest-cucurbit[n]uril-protein ternary supramolecular interactions.
    Scholtbach K; Venegas Í; Bohne C; Fuentealba D
    Photochem Photobiol Sci; 2015 Apr; 14(4):842-52. PubMed ID: 25683690
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cucurbit[7]uril induces superior probe performance for single-molecule detection.
    Martyn TA; Moore JL; Halterman RL; Yip WT
    J Am Chem Soc; 2007 Aug; 129(34):10338-9. PubMed ID: 17676851
    [No Abstract]   [Full Text] [Related]  

  • 76. NIR-triggered drug release from switchable rotaxane-functionalized silica-covered Au nanorods.
    Li M; Yan H; Teh C; Korzh V; Zhao Y
    Chem Commun (Camb); 2014 Sep; 50(68):9745-8. PubMed ID: 25019373
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Multifunctional envelope-type mesoporous silica nanoparticles for tumor-triggered targeting drug delivery.
    Zhang J; Yuan ZF; Wang Y; Chen WH; Luo GF; Cheng SX; Zhuo RX; Zhang XZ
    J Am Chem Soc; 2013 Apr; 135(13):5068-73. PubMed ID: 23464924
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Layer-by-layer supramolecular assemblies based on linear and star-shaped poly(glycerol methacrylate)s for doxorubicin delivery.
    Sun Y; Gao H; Yang YW; Wang A; Wu G; Wang Y; Fan Y; Ma J
    J Biomed Mater Res A; 2013 Aug; 101(8):2164-73. PubMed ID: 23281065
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Design of tumor-homing and pH-responsive polypeptide-doxorubicin nanoparticles with enhanced anticancer efficacy and reduced side effects.
    Hu J; Xie L; Zhao W; Sun M; Liu X; Gao W
    Chem Commun (Camb); 2015 Jul; 51(57):11405-8. PubMed ID: 26086450
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Development of a polyoxometallate-based photocatalyst assembled with cucurbit[6]uril via hydrogen bonds for azo dyes degradation.
    Cao M; Lin J; Lü J; You Y; Liu T; Cao R
    J Hazard Mater; 2011 Feb; 186(1):948-51. PubMed ID: 21130567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.